Dudediligence.

Oramed Pharmaceuticals Inc

ORMPNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,341,532

4 notices · 280,360 sh

PLANNED · FORM 144REPORTED · FORM 4none, Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: Avi Gabay, Form 1442026-10-01: Joshua Hexter, Form 1442026-07-01: Hexter Joshua, Form 1442026-07-01: Gabay Avraham, Form 144
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-10-01Avi Gabay, Chief Financial Officer$93,400
20,000 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-10-01Joshua Hexter, COO & CBO$140,100
30,000 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-07-01Hexter Joshua, COO & CBO$658,970
137,000 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-07-01Gabay Avraham, Chief Financial Officer$449,062
93,360 shplan 2026-03-30Form 4s on file end Jun 23144 ↗